http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018378484-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28bdd00e6c180acf9ad99fa2004da77e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4433 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
filingDate | 2018-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_404962eee030b66f17fd9327882991f0 |
publicationDate | 2020-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2018378484-A1 |
titleOfInvention | Mitochondria targeting, MPTP regulation, and the reduction of mitochondrial reactive species |
abstract | Provided herewith is a compound that reacts with a reactive lipid species to form a non- toxic product or an active product. Also provided is a method of reducing a reactive lipid species. Additionally provided is a method of treating a mitochondrion in a patient comprising a mitochondrial dysfunction. In other embodiments, a compound is provided that reacts with an activating agent present at a mitochondrion to form an active product that inhibits or enhances the opening of a mitochondrial permeability transition pore (MPTP). In additional embodiments, a method of inhibiting or enhancing the opening of an MPTP is provided. Further provided is a nonpolar compound capable of crossing the blood-brain barrier (BBB) into the central nervous system (CNS). |
priorityDate | 2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2453.